SCHEMBL14918771

SCHEMBL14918771

CC(C)(COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1OP(=O)(O)O)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CC(=O)CCCO

nearest known ligand 0.88

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ NAA50 Q9GZZ1 2/20 0.84
▸ EP300 Q09472 3/20 0.81
▸ CHAT P28329 2/20 0.81
▸ AURKA O14965 2/20 0.81
▸ KAT5 Q92993 2/20 0.81
▸ KAT2B Q92831 1/20 0.81
▸ CREBBP Q92793 1/20 0.71
▸ NAA40 Q86UY6 1/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21314167 1.00 NAA50 (0.84) NAA50EP300CHATAURKAKAT5
SCHEMBL29806102 1.00 NAA50 (0.84) NAA50EP300CHATAURKAKAT5
SCHEMBL18925866 1.00 NAA50 (0.84) NAA50EP300CHATAURKAKAT5
SCHEMBL18838134 0.98 NAA50 (0.84) NAA50EP300CHATAURKAKAT5
SCHEMBL28813886 0.97 NAA50 (0.85) NAA50EP300CHATAURKAKAT5
SCHEMBL21874948 0.97 NAA50 (0.85) NAA50EP300CHATAURKAKAT5
SCHEMBL416543 0.97 NAA50 (0.85) NAA50EP300CHATAURKAKAT5
SCHEMBL15018707 0.97 NAA50 (0.85) NAA50EP300CHATAURKAKAT5
SCHEMBL12077703 0.97 NAA50 (0.86) NAA50EP300CHATAURKAKAT5
SCHEMBL18925864 0.96 NAA50 (0.87) NAA50EP300CHATAURKAKAT5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260028651-A1 METHOD OF PRODUCING & PROCESSING DIAMINES AGAIN BIO APS (DK) 2026-01-29 — — US claimed
US-12503711-B2 Method of producing and processing diamines to a diamine free base using a carbonate intermediate and an engineered microorganism GENOMATICA, INC. (US) 2025-12-23 — — US claimed
US-11702682-B2 Method of producing and processing diamines to a diamine free base using a carbonate intermediate and an engineered microorganism GENOMATICA, INC. (US) 2023-07-18 — — US claimed
EP-2898082-B1 PATHWAYS TO ADIPATE SEMIALDEHYDE AND OTHER ORGANIC PRODUCTS LCY BIOSCIENCES INC (CA) 2019-09-04 — — EP claimed
EP-3374512-A1 POLYPEPTIDES FOR CARBON-CARBON BOND FORMATION AND USES THEREOF INVISTA Textiles (U.K.) Limited (GB) 2018-09-19 — — EP claimed
US-9809833-B2 Pathways to adipate semialdehyde and other organic products BIOAMBER INC. (US) 2017-11-07 — — US claimed
EP-3237629-A1 METHOD OF PRODUCING&PROCESSING DIAMINES Genomatica, Inc. (US) 2017-11-01 — — EP claimed
EP-3218505-A1 METHODS AND MATERIALS FOR PRODUCING 6-CARBON MONOMERS Invista Technologies S.à r.l. (CH) 2017-09-20 — — EP claimed
WO-2017083656-A1 POLYPEPTIDES FOR CARBON-CARBON BOND FORMATION AND USES THEREOF INVISTA NORTH AMERICA S.A.R.L (US) 2017-05-18 — — WO claimed
WO-2016106367-A1 METHOD OF PRODUCING & PROCESSING DIAMINES GENOMATICA, INC. (US) 2016-06-30 — — WO claimed
US-20160160255-A1 Methods and Materials for Producing 6-Carbon Monomers INVISTA NORTH AMERICA S.A.R.L. 2016-06-09 — — US claimed
WO-2016077800-A1 METHODS AND MATERIALS FOR PRODUCING 6-CARBON MONOMERS Invista North America S.á.r.l. (US) 2016-05-19 — — WO claimed
US-20150291987-A1 PATHWAYS TO ADIPATE SEMIALDEHYDE AND OTHER ORGANIC PRODUCTS LCY BIOSCIENCES INC. (CA) 2015-10-15 — — US claimed
EP-2898082-A1 PATHWAYS TO ADIPATE SEMIALDEHYDE AND OTHER ORGANIC PRODUCTS Bioamber Inc. (US) 2015-07-29 — — EP claimed
WO-2014047407-A1 PATHWAYS TO ADIPATE SEMIALDEHYDE AND OTHER ORGANIC PRODUCTS BIOAMBER INC. (US) 2014-03-27 — — WO claimed
EP-4716746-A2 MICROORGANISMS AND METHODS FOR INCREASED DIAMINE PRODUCTION Genomatica, Inc. (US) 2026-04-01 — — EP disclosed
US-12577591-B2 Microorganisms and methods for increasing co-factors GENOMATICA, INC. (US) 2026-03-17 — — US disclosed
WO-2014047407-A1 PATHWAYS TO ADIPATE SEMIALDEHYDE AND OTHER ORGANIC PRODUCTS BIOAMBER INC. (US) 2014-03-27 — — WO disclosed
US-20130144029-A1 MICROORGANISMS AND METHODS FOR THE PRODUCTION OF CAPROLACTONE AGAIN BIO APS (DK) 2013-06-06 — — US disclosed
WO-2013067432-A1 MICROORGANISMS AND METHODS FOR THE PRODUCTION OF CAPROLACTONE GENOMATICA, INC. (US) 2013-05-10 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260028651-A1 METHOD OF PRODUCING & PROCESSING DIAMINES DDC, DAO, ODC1 NAA50 69/4885EP300 1948/4885CHAT 77/4885
US-12577591-B2 Microorganisms and methods for increasing co-factors ABAT, HADHB, MMAB NAA50 278/4885EP300 3766/4885CHAT 1499/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback